Carisma Therapeutics Inc. Total Assets
Carisma Therapeutics Inc. had Total Assets of $6.55 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2025-11-12
- 2025-09-30: Assets $6.55M.
- 2025-06-30: Assets $5.01M.
- 2025-03-31: Assets $15.95M.
- 2024-12-31: Assets $30.46M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2025-09-30 | $6.55M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $5.01M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $15.95M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $30.46M 10-Q · filed 2025-11-12 | |
| 2024-09-30 | $42.06M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $59.34M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $73.80M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $89.55M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $106.78M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $133.01M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $156.13M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $72.15M 10-K · filed 2024-04-01 | $189.17M 10-K · filed 2023-02-28 |
| 2022-09-30 | $199.72M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $176.16M 10-Q/A · filed 2022-08-25 | |
| 2022-03-31 | $225.84M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $240.75M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $235.67M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $241.05M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $186.41M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $122.82M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $109.03M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $101.21M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $104.67M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $114.36M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $119.40M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $127.61M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $105.44M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $111.56M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $119.30M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $123.71M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $80.29M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $75.10M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $72.27M 10-Q · filed 2017-11-17 | |
| 2017-06-30 | $95.05M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $99.07M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $104.10M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $79.58M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $9.27M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $14.33M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $36.83M 10-K · filed 2017-03-24 | |
| 2015-09-30 | $47.60M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $55.12M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $46.58M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $55.00M 10-K · filed 2016-03-25 | |
| 2014-09-30 | $36.98M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $46.82M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $55.23M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $11.24M 10-K · filed 2015-03-06 |